Research Article
Association of the Apolipoprotein E 2 Allele with Concurrent Occurrence of Endometrial Hyperplasia and Endometrial Carcinoma
Table 2
Tumor characteristics of patients with ECa.
| | Characteristics | EH + ECa () | ECa () | | | (%) | (%) |
| | Histopathologic grades | | G1 (well differentiated) | 34 (44.74) | 48 (25.81) | 0.003 | | G2 (moderately differentiated) | 28 (36.84) | 97 (52.15) | 0.029 | | G3 (poorly or undifferentiated) | 7 (9.21) | 8 (4.30) | 0.14 | | Gx (N/A) | 7 (9.21) | 33 (17.74) | 0.091 |
| | Histopathologic types (WHO/ISGP) | | Endometrioid adenocarcinoma | 71 (93.42) | 150 (80.65) | 0.009 | | Clear cell adenocarcinoma | 4 (5.26) | 1 (0.54) | 0.026 | | Adenosquamous carcinoma | 0 | 2 (1.08) | — | | Papillary serous adenocarcinoma | 1 (1.32) | 8 (4.30) | 0.45 | | x (N/A) | 0 | 25 (13.44) | — |
| | FIGO stages | | I | 67 (88.16) | 131 (70.43) | 0.002 | | II | 3 (3.95) | 30 (16.13) | 0.007 | | III | 2 (2.63) | 13 (6.99) | 0.24 | | IV | 2 (2.63) | 3 (1.61) | 0.63 | | X (N/A) | 2 (2.63) | 9 (4.84) | 0.52 |
|
|
N/A: not available. Significant results are in bold.
|
